French firm wins funds for work on HIV/AIDS, obesity

04/10/2013 | GenomeWeb Daily News (free registration)

Theradiag, an in vitro diagnostics and theranostics company based in France, will use $1.6 million from Oséo to design test kits as part of its collaborative effort with Splicos and the French National Center for Research and Science. The project, called CaReNA, is aimed at developing diagnostic tests and RNA-targeting therapeutics for obesity and HIV/AIDS.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC